Providers in Colorado who are administering the Pfizer COVID-19 vaccine can now vaccinate any Coloradan age 12 and up who wants the vaccine.
Minors under the age of 18 who wish to receive a COVID-19 vaccine need parental consent. Parents do not need to be present for the vaccination as long as consent is documented, but they should check with the vaccine provider to confirm. The state’s vaccine provider map includes information on which vaccine each location is administering. All of the state’s Community Vaccination Sites offer the Pfizer vaccine, and most do not require an appointment.
“We are excited to hear that we are able to offer this safe and effective vaccine to nearly 300,000 additional Coloradans between the ages of 12 and 15,” said Dr. Alexis Burakoff, a medical epidemiologist at CDPHE. “As more older Coloradans have accessed the vaccine, we are seeing higher rates of cases in teenagers and children. We know there is a clear correlation between high vaccination rates and low infection rates, and this vaccine can now provide relief for thousands of additional families across the state.”
Schools, childcare, and higher education account for the highest proportion of newly reported outbreaks currently.
The state will adjust the COVID-19 data dashboard to include all Coloradans ages 12 and up in the vaccine-eligible population when the website updates at 4 p.m., Thursday, May 13. This will add 299,206 Coloradans to the statewide and county populations used to determine county-level vaccination rates on the vaccine data dashboard, so vaccination rates will appear to temporarily decline.
On Monday, the FDA announced an amendment to the emergency use authorization for Pfizer’s COVID-19 vaccine to include children ages 12-15. The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices met today and approved the use of the Pfizer vaccine in this younger population. In a clinical trial, the Pfizer vaccine was shown to be safe and effective among people ages 12-15. The trial included 2,260 children ages 12-15 years old in the U.S. There were 18 cases of COVID-19 in the placebo (unvaccinated) group and none in the vaccinated group. The vaccine showed 100% efficacy in this trial.
There were no severe adverse events clearly associated with the vaccine in the trial. Side effects of the vaccine in this age group were similar to those seen among young adults (e.g., temporary sore arm, fatigue, headache, chills, muscle aches). CDC and FDA will continue monitoring for safety.
The Moderna and Janssen (Johnson & Johnson) vaccines continue to be available only to adults 18 years of age and older.
Continue to stay up to date by visiting covid19.colorado.gov.